Comment on: “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children”

Raymond A. Farkouh; Cassandra Hall-Murray; Rogier M. Klok; Betsy Hilton; Raul E. Isturiz

首页> 外文期刊>Infectious Diseases and Therapy >Comment on: “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children”

【24h】

Comment on: “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children”

机译：评论：“日本儿童中的10价肺炎球菌不可分型流感嗜血杆菌蛋白D结合疫苗和13价肺炎球菌疫苗的成本效益评价”

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Infectious Diseases and Therapy》 |2015年第2期|共7页
作者
Raymond A. Farkouh; Cassandra Hall-Murray; Rogier M. Klok; Betsy Hilton; Raul E. Isturiz;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类传染病;
关键词

相似文献

外文文献
中文文献
专利

1. Reply to Farkouh RA et al. Comment on “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children” [J] . Makoto Shiragami, Akiko Mizukami, Oscar Leeuwenkamp, Infectious Diseases and Therapy . 2015,第2期

机译：回复Farkouh RA等。评论“对日本儿童的10价肺炎球菌非分型流感嗜血杆菌D蛋白结合疫苗和13价肺炎球菌疫苗的成本效益评价”
2. Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children [J] . Makoto Shiragami, Akiko Mizukami, Oscar Leeuwenkamp, Infectious Diseases and Therapy . 2015,第1期

机译：10价肺炎球菌不可分型流感嗜血杆菌蛋白D结合疫苗和13价肺炎球菌疫苗在日本儿童中的成本效果评价。
3. A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand [J] . Lijoy Varghese, Louise Talbot, Andrea Govender, Applied health economics and health policy . 2018,第3期

机译：与新西兰通用大规模疫苗接种实施的13价肺炎球菌缀合物疫苗（PCV13）相比，10价肺炎球菌非典型血液植物甲型蛋白D缀合物（PHID-CV）的成本效益分析
4. Evaluation of the effectiveness of a 13-valent pneumococcal conjugated vaccine implemented in the municipality of Campos de Goytacazes, Brazil [C] . Kury C.M.H., Vitral C.L, Kury M.M.H., World Congress of the World Society for Pediatric Infectious Diseases . 2014

机译：评估在巴西坎波德·戈科塔斯市政府实施的13价肺炎球菌共轭疫苗的有效性
5. Impact of Pneumococcal Conjugate Vaccine Thirteen Valent on the Reduction of Invasive Pneumococcal Disease. [D] . Coulibaly, Aissata. 2016

机译：肺炎球菌结合疫苗十三价对减少侵袭性肺炎球菌疾病的影响。
6. Reply to Farkouh RA et al. Comment on Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children [O] . Makoto Shiragami, Akiko Mizukami, Oscar Leeuwenkamp, -1

机译：回复Farkouh RA等。评论对日本儿童的10价肺炎球菌非分型流感嗜血杆菌D蛋白结合疫苗和13价肺炎球菌疫苗的成本效益评估
7. Reply to Farkouh RA et al. Comment on “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children” [O] . Makoto Shiragami, Akiko Mizukami, Oscar Leeuwenkamp, 2015

机译：回复Farkouh RA等。评论“对日本儿童10价肺炎球菌非分型流感嗜血杆菌D蛋白结合疫苗和13价肺炎球菌疫苗的成本效益评价”
8. Invasive Pneumococcal Disease and 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Coverage Among Children Aged Less Than or Equal to 59 Months, Selected U.S. Regions, 2010-2011 [R] . 2011

机译：侵入性肺炎球菌疾病和13价肺炎球菌结合疫苗（pCV13）覆盖率小于或等于59个月的儿童，2010 - 2011年选定的美国地区

Comment on: “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children”

著录项

相似文献

相关主题

期刊订阅